Recall | Medicines | 01/09/2017

"AOP Orphan Pharmaceuticals AG" informed its supplied customers by letter dated August 31, 2017, that "Thromboreductin 1.0 mg Capsules" was placed on the market as a medicinal product not authorized in Austria in this strength with defective packaging, since the labeling and directions for use were not approved by the BASG.

Name of the medicinal product Thromboreductin 1,0 mg Kapseln
Marketing authorisation number(s) keine
Marketing authorisation holder Inverkehrbringer: AOP Orphan Pharmaceuticals AG
Batch number(s) E316A
Classification of the recall2
BASG reference number INS-640.001-2234

Further inquiry note